产前检查免疫检验项目应用的价值评估
2018-12-24丁友辉
丁友辉
[摘要] 目的 分析产前检查免疫检验项目的应用价值。 方法 选取2016年11月~2018年1月在我院进行分娩的产妇80例作为观察对象,将80例产妇分成免疫组与常规组,各组40例。常规组产前实施常规检验,免疫组则在常规检验的基础之上进行免疫项目检验,观察两组方法的临床检验效果。 结果 免疫组孕妇乙型肝炎、梅毒与微生物感染发生率和高危妊娠发生率要显著低于常规组孕妇,差异有统计学意义(P<0.05)。80例孕妇的HIV抗体、乙肝抗体、丙肝抗体等阳性检出率分别为0(0/80)、7.5%(6/80)、5.0%(4/80)。 结论 孕妇在产前进行免疫项目检验,可以早期对孕妇身体状况与胎儿的健康状态实施检测判断,能够确保母亲与婴儿的安全,降低产妇妊娠与分娩时期的并发症发生率,为产妇安全分娩提供重要保障。
[关键词] 产前检查;免疫检验;并发症;应用价值
[中图分类号] R446.6 [文献标识码] B [文章编号] 1673-9701(2018)27-0132-03
[Abstract] Objective To analyze the application value of prenatal examination immunoassay project. Methods 80 puerperas who gave birth at our Hospital in from November 2016 to January 2018 were enrolled. The 80 puerperas were divided into immunization group and routine group, with 40 women in each group. The routine group was routinely tested before delivery, and the immunization group was tested on the basis of routine tests. The clinical test results between the two groups were observed. Results The incidence of hepatitis B, syphilis and microbial infection and the incidence of high-risk pregnancy in the immunization group was significantly lower than that in the routine group. The differences between the two groups were statistically significant(P<0.05).The positive detection rates of HIV antibody, hepatitis B antibody and hepatitis C antibody in 80 pregnant women were 0(0/80), 7.5%(6/80), and 5.0%(4/80), respectively. Conclusion Prenatal examination immunoassay in pregnant women can judge the health status of pregnant women and the fetus at an early stage. It can ensure the safety of mothers and babies, reduce the incidence of complications during maternal pregnancy and childbirth,and provide important guarantee for safe delivery.
[Key words] Prenatal examination; Immunoassay; Complications; Application value
隨着医疗科技的不断进步,人们对于医疗质量要求也相对较高,特别是在临床检验当中,检验属于治疗组成的一部分,临床检验准确度与临床治疗效果密切相关[1]。产前检验指的是在孕妇妊娠期间,对孕妇自身与胎儿实施检验,包括孕妇生命体征、高危妊娠症状的有无等,达到早发现、早治疗与早预防的目的[2]。而产前检验的项目一直是临床争议的问题。本次就2016年11月~2018年1月在本院进行分娩的产妇80例作为观察对象,分析产前免疫检验项目的临床应用价值,现报道如下。
1 资料与方法
1.1 一般资料
选2016年11月~2018年1月在广东茂名市高州中医院进行分娩的产妇80例作为观察对象,将其分成免疫组与常规组,各40例。常规组孕妇年龄22~40岁,平均(30.6±4.2)岁。怀孕周期18~40周,平均(27.8±8.6)周。26例孕妇为初产妇,14例孕妇为经产妇。免疫组孕妇年龄23~41岁,平均(30.4±4.1)岁。怀孕周期18~40周,平均(28.0±8.4)周。25例孕妇为初产妇,15例孕妇为经产妇。两组孕妇一般资料进行比较,差异无统计学意义(P>0.05),具有可比性。……
